Cuprina Holdings (cayman) LTD revenue

Cuprina Holdings (cayman) LTD's revenue was $38,204 in fiscal 2025, up 5.6% on the year before. Since fiscal 2022 ($41,067) it has grown at a compound -2.4% a year.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cuprina Holdings (cayman) LTD: revenue history, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	41	75	36	38
Growth on the year before	—	+82.8%	−51.8%	+5.6%
Gross profit	14	27	−2	−0

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Cuprina Holdings (cayman) LTD	$38,204	5.6%	—
Phaos Technology Holdings (cayman) Ltd	$102,806	-18.2%	—
Pavmed Inc.	$112,000	-89.0%	-49.6%
Nexalin Technology, Inc.	$217,155	24.2%	-30.6%
Qtrex Quantum Ltd.	$289,000	—	—
Heartsciences Inc.	$4,519	-64.2%	—

Compare with peers

Head to head: CUPR vs POAS CUPR vs PAVM CUPR vs NXL CUPR vs HSCS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cuprina Holdings (cayman) LTD's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Cuprina Holdings (cayman) LTD.